Concepedia

M. Gooderham

MG

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2022

Affiliations

Case Western Reserve University(Current)

M. Gooderham is an author at Case Western Reserve University specializing in psoriatic disease, dermatology, and tyrosine kinase inhibition.

Publications per year

2022–2022

1

Publications

1

AB0890 Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: 52-Week Efficacy Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Trials

Richard B. Warren, A. Armstrong, M. Gooderham et al. · Annals of the Rheumatic Diseases · 2022 · 10 citations · Full text

Medicine, Dermatology, Pharmacology +12

1–1 of 1